New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients

Transplant Proc. 1993 Feb;25(1 Pt 2):1032-3.

Authors

C Sauron¹, P Berthoux, F Berthoux, E Alamartine, N Diab, C Broyet, J Hacini

Affiliation

¹ Service de Néphrologie, CHU de Saint-Etienne, Hôpital Nord, Saint-Priest-en-Jarez, France.

PMID: 8382847

No abstract available

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Blood Volume
Dipeptides / therapeutic use*
Erythropoietin / blood
Hematocrit
Hemoglobins / analysis
Humans
Kidney Transplantation / adverse effects*
Lisinopril
Polycythemia / blood
Polycythemia / drug therapy*
Polycythemia / etiology
Postoperative Complications / blood
Postoperative Complications / drug therapy*

Substances

Angiotensin-Converting Enzyme Inhibitors
Dipeptides
Hemoglobins
Erythropoietin
Lisinopril